Laboratory Medicine ›› 2023, Vol. 38 ›› Issue (2): 106-111.DOI: 10.3969/j.issn.1673-8640.2023.02.002
Previous Articles Next Articles
CAI Xiaoyi1, LOU Dan2(), YANG Xingge2, WANG Jian3
Received:
2022-03-19
Revised:
2022-11-02
Online:
2023-02-28
Published:
2023-04-17
CLC Number:
CAI Xiaoyi, LOU Dan, YANG Xingge, WANG Jian. Genetic analysis on 15 cases of suspected Duchenne muscular dystrophy/Becker muscular dystrophy[J]. Laboratory Medicine, 2023, 38(2): 106-111.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2023.02.002
病例编号 | 性别 | 年龄 | CK/ (U/L) | ALT/(IU/L) | MYO/(μg/L) | Gower征 | 腓肠肌状态 | 行走能力 | 肌无力 | 肌电图检查 |
---|---|---|---|---|---|---|---|---|---|---|
1 | 男 | 3岁 | 7 852 | 235 | 336 | 阳性 | 肥大 | 正常 | 否 | 肌源性损伤 |
2 | 男 | 15岁 | 3 605 | 34 | 225 | 阳性 | 肥大 | 行走不稳 | 否 | 肌源性损伤 |
3 | 男 | 4岁 | 11 367 | 270 | 149 | 阳性 | 肥大 | 行走不稳 | 否 | 肌源性损伤 |
4 | 男 | 5岁10个月 | 6 411 | 360 | 512 | 阳性 | 肥大 | 正常 | 否 | 肌源性损伤 |
5 | 女 | 3岁7个月 | 5 444 | 154 | 194 | 阳性 | 肥大 | 正常 | 否 | 肌源性损伤 |
6 | 男 | 2岁3个月 | 14 216 | 503 | 334 | 阳性 | 肥大 | 正常 | 否 | 肌源性损伤 |
7 | 男 | 7岁 | 4 433 | 382 | 479 | 阳性 | 肥大 | 行走不稳 | 是 | 肌源性损伤 |
8 | 女 | 2岁2个月 | 2 025 | 97 | 61 | 阳性 | 稍肥大 | 正常 | 是 | 肌源性损伤 |
9 | 女 | 1岁 | 2 594 | 111 | 271 | 阳性 | 稍肥大 | 扶走 | 否 | 肌源性损伤 |
10 | 男 | 4岁 | 5 523 | 156 | 733 | 阴性 | 正常 | 正常 | 否 | 肌源性损伤 |
11 | 男 | 5岁2个月 | 5 873 | 393 | 610 | 阳性 | 肥大 | 正常 | 否 | 肌源性损伤 |
12 | 男 | 11岁 | 8 908 | 101 | 379 | 阳性 | 肥大 | 正常 | 否 | 肌源性损伤 |
13 | 男 | 17岁 | 4 235 | 88 | 510 | 阳性 | 肥大 | 丧失 | 否 | 肌源性损伤 |
14 | 男 | 7岁7个月 | 5 763 | 115 | 267 | 阳性 | 肥大 | 行走不稳 | 是 | 肌源性损伤 |
15 | 男 | 3岁9个月 | 226 | 35 | 50 | 阴性 | 正常 | 丧失 | 是 | 肌源性损伤 |
病例编号 | 性别 | 年龄 | CK/ (U/L) | ALT/(IU/L) | MYO/(μg/L) | Gower征 | 腓肠肌状态 | 行走能力 | 肌无力 | 肌电图检查 |
---|---|---|---|---|---|---|---|---|---|---|
1 | 男 | 3岁 | 7 852 | 235 | 336 | 阳性 | 肥大 | 正常 | 否 | 肌源性损伤 |
2 | 男 | 15岁 | 3 605 | 34 | 225 | 阳性 | 肥大 | 行走不稳 | 否 | 肌源性损伤 |
3 | 男 | 4岁 | 11 367 | 270 | 149 | 阳性 | 肥大 | 行走不稳 | 否 | 肌源性损伤 |
4 | 男 | 5岁10个月 | 6 411 | 360 | 512 | 阳性 | 肥大 | 正常 | 否 | 肌源性损伤 |
5 | 女 | 3岁7个月 | 5 444 | 154 | 194 | 阳性 | 肥大 | 正常 | 否 | 肌源性损伤 |
6 | 男 | 2岁3个月 | 14 216 | 503 | 334 | 阳性 | 肥大 | 正常 | 否 | 肌源性损伤 |
7 | 男 | 7岁 | 4 433 | 382 | 479 | 阳性 | 肥大 | 行走不稳 | 是 | 肌源性损伤 |
8 | 女 | 2岁2个月 | 2 025 | 97 | 61 | 阳性 | 稍肥大 | 正常 | 是 | 肌源性损伤 |
9 | 女 | 1岁 | 2 594 | 111 | 271 | 阳性 | 稍肥大 | 扶走 | 否 | 肌源性损伤 |
10 | 男 | 4岁 | 5 523 | 156 | 733 | 阴性 | 正常 | 正常 | 否 | 肌源性损伤 |
11 | 男 | 5岁2个月 | 5 873 | 393 | 610 | 阳性 | 肥大 | 正常 | 否 | 肌源性损伤 |
12 | 男 | 11岁 | 8 908 | 101 | 379 | 阳性 | 肥大 | 正常 | 否 | 肌源性损伤 |
13 | 男 | 17岁 | 4 235 | 88 | 510 | 阳性 | 肥大 | 丧失 | 否 | 肌源性损伤 |
14 | 男 | 7岁7个月 | 5 763 | 115 | 267 | 阳性 | 肥大 | 行走不稳 | 是 | 肌源性损伤 |
15 | 男 | 3岁9个月 | 226 | 35 | 50 | 阴性 | 正常 | 丧失 | 是 | 肌源性损伤 |
病例编号 | 致病基因 | 变异(DNA) | 氨基酸改变① | 检测方法 | 变异性质 | 家系成员检测 |
---|---|---|---|---|---|---|
1 | DMD (NM_004006.3) | Exon 22 del | p.Ile935Serfs*30 | MLPA | 半合子 | 母亲杂合携带, 弟弟半合子(DMD患者) |
2 | DMD | Exons 39-43 del | p.Asn1817Alafs*3 | MLPA | 半合子 | 未接受检测 |
3 | DMD | c.2168+1G>T | WES | 半合子 | 未接受检测 | |
4 | DMD | Exons 1-79 del | MLPA | 半合子 | 未接受检测 | |
5 | DMD | Exons 50-52 del | p.Arg2401Leufs*22 | MLPA | 杂合子 | 父母均为野生型 |
6 | DMD | Exons 22-23 del | p.Ile935Lysfs*12 | MLPA | 半合子 | 母亲杂合携带 |
7 | DMD | Exons 49-52 del | p.Glu2367Leufs*22 | MLPA | 半合子 | 未接受检测 |
8 | DMD | Exons 45-53 del | p.Glu2366_Gln2624del | MLPA | 杂合子 | 未接受检测 |
9 | DMD | c.9917_9923del | p.Thr3306Serfs*22 | WES | 杂合子 | 父母均为野生型 |
10 | DMD | Exons 45-48 del | p.Glu2146_Glu2366del | MLPA | 半合子 | 母亲杂合携带 |
11 | DMD | Exons 45-53 del | p.Glu2366_Gln2624del | MLPA | 半合子 | 未接受检测 |
12 | DMD | Exons 3-7 del | p.Phe32Metfs*13 | MLPA | 半合子 | 未接受检测 |
13 | DMD | Exons 52-53 del | p.Ala2514_Gln2624del | MLPA | 半合子 | 未接受检测 |
14 | DMD | Exons 33-45 del | p.Asn1507Alafs*17 | MLPA | 半合子 | 未接受检测 |
15 | LAMA2 (NM_000426.4) | c.819+1G>A | WES | 杂合子 | 父亲杂合携带 | |
c.1884G>A | p.Glu628Glu | WES | 杂合子 | 母亲杂合携带 |
病例编号 | 致病基因 | 变异(DNA) | 氨基酸改变① | 检测方法 | 变异性质 | 家系成员检测 |
---|---|---|---|---|---|---|
1 | DMD (NM_004006.3) | Exon 22 del | p.Ile935Serfs*30 | MLPA | 半合子 | 母亲杂合携带, 弟弟半合子(DMD患者) |
2 | DMD | Exons 39-43 del | p.Asn1817Alafs*3 | MLPA | 半合子 | 未接受检测 |
3 | DMD | c.2168+1G>T | WES | 半合子 | 未接受检测 | |
4 | DMD | Exons 1-79 del | MLPA | 半合子 | 未接受检测 | |
5 | DMD | Exons 50-52 del | p.Arg2401Leufs*22 | MLPA | 杂合子 | 父母均为野生型 |
6 | DMD | Exons 22-23 del | p.Ile935Lysfs*12 | MLPA | 半合子 | 母亲杂合携带 |
7 | DMD | Exons 49-52 del | p.Glu2367Leufs*22 | MLPA | 半合子 | 未接受检测 |
8 | DMD | Exons 45-53 del | p.Glu2366_Gln2624del | MLPA | 杂合子 | 未接受检测 |
9 | DMD | c.9917_9923del | p.Thr3306Serfs*22 | WES | 杂合子 | 父母均为野生型 |
10 | DMD | Exons 45-48 del | p.Glu2146_Glu2366del | MLPA | 半合子 | 母亲杂合携带 |
11 | DMD | Exons 45-53 del | p.Glu2366_Gln2624del | MLPA | 半合子 | 未接受检测 |
12 | DMD | Exons 3-7 del | p.Phe32Metfs*13 | MLPA | 半合子 | 未接受检测 |
13 | DMD | Exons 52-53 del | p.Ala2514_Gln2624del | MLPA | 半合子 | 未接受检测 |
14 | DMD | Exons 33-45 del | p.Asn1507Alafs*17 | MLPA | 半合子 | 未接受检测 |
15 | LAMA2 (NM_000426.4) | c.819+1G>A | WES | 杂合子 | 父亲杂合携带 | |
c.1884G>A | p.Glu628Glu | WES | 杂合子 | 母亲杂合携带 |
项目 | 变异位点 | ACMG证据 | 致病性 |
---|---|---|---|
DMD基因 | |||
病例1 | Exon 22 del | PVS1+PM2+PP4 | 致病 |
病例2 | Exons 39-43 del | PVS1+PM2+PP4 | 致病 |
病例3 | c.2168+1G>T | PVS1+PM2+PP4 | 致病 |
病例4 | Exons 1-79 del | PVS1+PM2+PP4 | 致病 |
病例5 | Exons 50-52 del | PVS1+PM1+PM2+PP4 | 致病 |
病例6 | Exons 22-23 del | PVS1+PM2+PP4 | 致病 |
病例7 | Exons 49-52 del | PVS1+PM1+PM2+PP4 | 致病 |
病例8 | Exons 45-53 del | PM1+PM2+PM4+PP4 | 可能致病 |
病例9 | c.9917_9923 del | PVS1+PM2+PP4 | 致病 |
病例10 | Exons 45-48 del | PM1+PM2+PM4+PP4 | 可能致病 |
病例11 | Exons 3-7 del | PVS1+PM2+PP4 | 致病 |
病例12 | Exons 52-53 del | PM1+PM2+PM4+PP4 | 可能致病 |
病例13 | Exons 33-45 del | PVS1+PM2+PP4 | 致病 |
LAMA2基因 | |||
病例14 | c.819+1G>A | PVS1+PM2+PM3+PP4 | 致病 |
病例15 | c.1884G>A | PM2+PM3+PP3+PP4 | 可能致病 |
项目 | 变异位点 | ACMG证据 | 致病性 |
---|---|---|---|
DMD基因 | |||
病例1 | Exon 22 del | PVS1+PM2+PP4 | 致病 |
病例2 | Exons 39-43 del | PVS1+PM2+PP4 | 致病 |
病例3 | c.2168+1G>T | PVS1+PM2+PP4 | 致病 |
病例4 | Exons 1-79 del | PVS1+PM2+PP4 | 致病 |
病例5 | Exons 50-52 del | PVS1+PM1+PM2+PP4 | 致病 |
病例6 | Exons 22-23 del | PVS1+PM2+PP4 | 致病 |
病例7 | Exons 49-52 del | PVS1+PM1+PM2+PP4 | 致病 |
病例8 | Exons 45-53 del | PM1+PM2+PM4+PP4 | 可能致病 |
病例9 | c.9917_9923 del | PVS1+PM2+PP4 | 致病 |
病例10 | Exons 45-48 del | PM1+PM2+PM4+PP4 | 可能致病 |
病例11 | Exons 3-7 del | PVS1+PM2+PP4 | 致病 |
病例12 | Exons 52-53 del | PM1+PM2+PM4+PP4 | 可能致病 |
病例13 | Exons 33-45 del | PVS1+PM2+PP4 | 致病 |
LAMA2基因 | |||
病例14 | c.819+1G>A | PVS1+PM2+PM3+PP4 | 致病 |
病例15 | c.1884G>A | PM2+PM3+PP3+PP4 | 可能致病 |
[1] |
CRISAFULLI S, SULTANA J, FONTANA A, et al. Global epidemiology of Duchenne muscular dystrophy:an updated systematic review and meta-analysis[J]. Orphanet J Rare Dis, 2020, 15(1):141.
DOI |
[2] |
GILIBERTO F, RADIC C P, LUCE L, et al. Symptomatic female carriers of Duchenne muscular dystrophy (DMD):genetic and clinical characterization[J]. J Neurol Sci, 2014, 336(1-2):36-41.
DOI URL |
[3] |
QUIJANO-ROY S, HABERLOVA J, CASTIGLIONI C, et al. Diagnostic interest of whole-body MRI in early- and late-onset LAMA2 muscular dystrophies:a large international cohort[J]. J Neurol, 2022, 269(5):2414-2429.
DOI |
[4] | 赵炜, 姜楠, 李朔, 等. 假性肥大型肌营养不良症的遗传学分析及产前诊断[J]. 中华妇产科杂志, 2019, 54(4):6. |
[5] |
WANG J, ZHANG W, JIANG H, et al. Mutations in HFM1 in recessive primary ovarian insufficiency[J]. N Engl J Med, 2014, 370(10):972-974.
DOI URL |
[6] | 北京医学会罕见病分会, 北京医学会神经内科分会神经肌肉病学组, 中国肌营养不良协作组. Duchenne型肌营养不良多学科管理专家共识[J]. 中华医学杂志, 2018, 98(35):12. |
[7] | RICHARDS S, AZIZ N, BALE S, et al. Standards and guidelines for the interpretation of sequence variants:a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5):405-424. |
[8] |
MUNTONI F, TORELLI S, FERLINI A. Dystrophin and mutations:one gene,several proteins,multiple phenotypes[J]. Lancet Neurol, 2003, 2(12):731-740.
DOI URL |
[9] |
PATEL K M, BHATT A D, SHAH K, et al. Molecular diagnosis of muscular dystrophy patients in western Indian population:a comprehensive mutation analysis using amplicon sequencing[J]. Front Genet, 2021, 12:770350.
DOI URL |
[10] |
NERI M, ROSSI R, TRABANELLI C, et al. The genetic landscape of dystrophin mutations in Italy:a nationwide study[J]. Front Genet, 2020, 11:131.
DOI URL |
[11] |
WHITE S J, DEN DUNNEN J T. Copy number variation in the genome;the human DMD gene as an example[J]. Cytogenet Genome Res, 2006, 115(3-4):240-246.
DOI URL |
[12] |
LI X, ZHAO L, ZHOU S, et al. A comprehensive database of Duchenne and Becker muscular dystrophy patients(0-18 years old) in East China[J]. Orphanet J Rare Dis, 2015, 10:5.
DOI URL |
[13] |
OUDET C, HANAUER A, CLEMENS P, et al. Two hot spots of recombination in the DMD gene correlate with the deletion prone regions[J]. Hum Mol Genet, 1992, 1(8):599-603.
DOI URL |
[14] |
FROMER M, MORAN J L, CHAMBERT K, et al. Discovery and statistical genotyping of copy-number variation from whole-exome sequencing depth[J]. Am J Hum Genet, 2012, 91(4):597-607.
DOI PMID |
[15] | HU X, LI N, XU Y, et al. Proband-only medical exome sequencing as a cost-effective first-tier genetic diagnostic test for patients without prior molecular tests and clinical diagnosis in a developing country:the China experience[J]. Genet Med, 2018, 20(9):1045-1053. |
[16] |
SALMANINEJAD A, JAFARI ABARGHAN Y, BOZORG QOMI S, et al. Common therapeutic advances for Duchenne muscular dystrophy(DMD)[J]. Int J Neurosci, 2021, 131(4):370-389.
DOI URL |
[17] | 李媛媛, 刘卓, 欧阳胜荣, 等. 以转氨酶升高为首发表现的假肥大型肌营养不良临床分析[J]. 中华实用儿科临床杂志, 2017, 32(24):5. |
[18] |
NALLAMILLI B R R, CHAKRAVORTY S, KESARI A, et al. Genetic landscape and novel disease mechanisms from a large LGMD cohort of 4 656 patients[J]. Ann Clin Transl Neurol, 2018, 5(12):1574-1587.
DOI URL |
[19] |
OLIVEIRA J, GRUBER A, CARDOSO M, et al. LAMA2 gene mutation update:toward a more comprehensive picture of the laminin-α2 variome and its related phenotypes[J]. Hum Mutat, 2018, 39(10):1314-1337.
DOI URL |
[20] |
SILVA T H D, ANEQUINI I P, FÁVERO F M, et al. Functional performance and muscular strength in symptomatic female carriers of Duchenne muscular dystrophy[J]. Arq Neuropsiquiatr, 2020, 78(3):143-148.
DOI URL |
[21] |
KAMAKURA K, KAWAI M, ARAHATA K, et al. A manifesting carrier of Duchenne muscular dystrophy with severe myocardial symptoms[J]. J Neurol, 1990, 237(8):483-485.
PMID |
[22] |
HOOGERWAARD E M, VAN DER WOUW P A, Wilde A A, et al. Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy[J]. Neuromuscul Disord, 1999, 9(5):347-351.
DOI URL |
[23] |
PANNING B. X-chromosome inactivation:the molecular basis of silencing[J]. J Biol, 2008, 7(8):30.
DOI URL |
[24] |
VIGGIANO E, PICILLO E, CIRILLO A, et al. Comparison of X-chromosome inactivation in Duchenne muscle/myocardium-manifesting carriers,non-manifesting carriers and related daughters[J]. Clin Genet, 2013, 84(3):265-270.
DOI URL |
[25] |
VIGGIANO E, ERGOLI M, PICILLO E, et al. Determining the role of skewed X-chromosome inactivation in developing muscle symptoms in carriers of Duchenne muscular dystrophy[J]. Hum Genet, 2016, 135(7):685-698.
DOI PMID |
[1] | JIANG Zhu, TAN Jianxin, TAN Juan, LUO Chunyu, XU Zhengfeng. Research progress in genetic diagnostic methods of fragile X syndrome [J]. Laboratory Medicine, 2024, 39(2): 107-113. |
[2] | LU Yaya, PENG Huifang, WANG Jian, LOU Dan. Genetic analysis of Witteveen-Kolk syndrome caused by Sin3A variation [J]. Laboratory Medicine, 2024, 39(2): 126-131. |
[3] | YU Tingting, WANG Jian. Progress and challenges in diagnosis and treatment of rare diseases [J]. Laboratory Medicine, 2023, 38(2): 103-105. |
[4] | TONG Wenjia, SONG Conglei, XU Yuanyuan, LI Min, JIN Danqun. Genetic analysis of Poirier-Bienvenu neurodevelopmental syndrome [J]. Laboratory Medicine, 2023, 38(2): 112-116. |
[5] | CAI Chunyan, SHANGGUAN Huakun, WU Wenyong, ZHANG Ying, YUAN Xin, CHEN Ruimin. Clinical phenotypes and genetics analysis of X-linked intellectual disability caused by HUWE1 gene variation [J]. Laboratory Medicine, 2023, 38(2): 117-123. |
[6] | CHENG Huanhuan, ZHAO Yuwei. Clinical characteristic and genetic test analysis of 2 neonates with congenital distal arthrogryposis caused by MYH3 mutation [J]. Laboratory Medicine, 2023, 38(2): 124-129. |
[7] | ZHANG Zhixiang, TIAN Hengfeng, HENG Erhu. Genetic test and literature review in a child with congenital glycosylation disorder type Ⅰq [J]. Laboratory Medicine, 2023, 38(2): 137-142. |
[8] | WANG Yanmin, TIAN Guoli, JI Wei, ZHANG Xiaofen. Application of creatine kinase isoenzyme MM in screening neonatal Duchenne muscular dystrophy [J]. Laboratory Medicine, 2020, 35(11): 1115-1119. |
[9] | CHEN Jiuming, GU Mingmin, SUN Shunchang. Genetic diagnosis of spinocerebellar ataxia by PCR amplification and Sanger sequencing [J]. Laboratory Medicine, 2019, 34(6): 534-538. |
[10] | DU Chengkan, SUN Hengjuan, LAN Xiaoping, YANG Yongchen, SUN Jiapeng, XU Wuhen, ZHANG Hong. Fixed cell DNA for determining Prader-Willi syndrome [J]. Laboratory Medicine, 2017, 32(11): 1008-1012. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||